Valuation : Remus Pharmaceuticals Limited

Market Cap 7.32B 77.53M 66.71M 62.77M 57.34M 107M 108M 742M 288M 3.76B 291M 285M 12.1B P/E 2024
45.4x
P/E 2025 45.4x
Enterprise Value 7.28B 77.08M 66.32M 62.4M 57M 107M 107M 737M 286M 3.73B 289M 283M 12.03B EV / Sales 2024
4.69x
EV / Sales 2025 2.12x
Free-Float
24.75%
Yield 2024
0.09%
Yield 2025 0.07%
1 day-0.45%
1 week-3.78%
Current month-1.05%
1 month+15.74%
3 months+26.57%
6 months+44.71%
Current year+26.75%
1 week 866
Extreme 866
921.95
1 month 815
Extreme 815
987.5
Current year 580
Extreme 580
987.5
1 year 580
Extreme 580
987.5
3 years 506.25
Extreme 506.25
1,417.38
5 years 213.91
Extreme 213.90625
1,417.38
10 years 213.91
Extreme 213.90625
1,417.38
Manager TitleAgeSince
Chief Executive Officer 39 15/01/2023
Director of Finance/CFO - 08/07/2026
Compliance Officer - 05/01/2023
Director TitleAgeSince
Director/Board Member 39 20/09/2015
Chairman 41 20/09/2015
Director/Board Member 38 20/09/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%-3.78%+5.85%+65.87% 110M
-0.88%-2.15%+58.05%+105.91% 1,024B
-1.15%+2.68%+54.25%+71.29% 663B
-1.44%+0.38%+20.65%+75.54% 453B
+0.14%-0.47%+30.20%+40.61% 352B
-1.33%+4.72%+24.62%+47.60% 304B
-1.15%+0.30%-0.69%+11.83% 252B
-1.55%+1.11%+54.15%+72.13% 236B
-0.88%+1.15%-14.60%-54.84% 206B
-0.15%+3.65%+31.24%+100.90% 187B
Average -0.88%+0.60%+26.37%+53.68% 367.85B
Weighted average by Cap. -0.96%+0.55%+37.63%+67.00%

Financials

2024 2025
Net sales 2.13B 22.54M 19.4M 18.25M 16.67M 31.19M 31.28M 216M 83.7M 1.09B 84.66M 82.81M 3.52B 6.2B 65.71M 56.54M 53.2M 48.59M 90.9M 91.15M 629M 244M 3.18B 247M 241M 10.25B
Net income 215M 2.28M 1.96M 1.85M 1.69M 3.16M 3.16M 21.82M 8.47M 110M 8.57M 8.38M 356M 291M 3.08M 2.65M 2.49M 2.28M 4.26M 4.27M 29.46M 11.43M 149M 11.56M 11.31M 480M
Net Debt -178M -1.89M -1.62M -1.53M -1.39M -2.61M -2.62M -18.03M -7M -91.31M -7.08M -6.92M -294M -42.9M -454K -391K -368K -336K -629K -630K -4.35M -1.69M -22.01M -1.71M -1.67M -70.91M
Logo Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
Employees
-
Date Price Change Volume
04/09/26 ₹890.05 -0.45% 3,000
03/09/26 ₹894.10 +0.99% 8,600
02/09/26 ₹885.30 +2.16% 3,400
01/09/26 ₹866.60 -3.65% 3,800
31/08/26 ₹899.45 -2.76% 7,000
  1. Stock Market
  2. Stocks
  3. REMUS Stock